$UTMD Q2 '26 Earnings Results & Recap
• Reported GAAP EPS of $0.84 down -10.64% YoY
• Reported revenue of $8.53M down -14.31% YoY
• Utah Medical Products, Inc. projects a sales decline of 10-13% for the full year 2026 compared to 2025, citing continued substantial uncertainty and slower than expected new product sales gains.